Adapting vaccine formulation to the neonatal context is required to obtain safe protection against the respiratory syncytial virus - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2012

Adapting vaccine formulation to the neonatal context is required to obtain safe protection against the respiratory syncytial virus

Résumé

absent
Fichier non déposé

Dates et versions

hal-01003266 , version 1 (10-06-2014)

Identifiants

  • HAL Id : hal-01003266 , version 1
  • PRODINRA : 180783
  • WOS : 000309189106180

Citer

Aude Remot, Xavier Roux, Catherine Dubuquoy, Julie Bernard, Mohammed Moudjou, et al.. Adapting vaccine formulation to the neonatal context is required to obtain safe protection against the respiratory syncytial virus. European Congress of Immunology, Sep 2012, Glasgow, Scotland, United Kingdom. pp.727. ⟨hal-01003266⟩
131 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More